ERBB2 and cancer: The lower Ki-67 levels seen in our HER2-low group likely reflect a biologically less aggressive tumor type, supporting the theory that HER2-low cancers, especially those driven by hormone signaling, tend to fall within luminal A or B subtypes, which are known for slower growth rates [17,19].